101-05-3
101-05-3
Chemical Structure
Anilazine
- CAS No.: 101-05-3
- Formula:C9H5Cl3N4
- Molecular Weight:275.52
IUPAC Name: 4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine
InChIKey: IMHBYKMAHXWHRP-UHFFFAOYSA-N
SMILES: ClC1=CC=CC=C1NC2=NC(Cl)=NC(Cl)=N2
Biological Activity: Anilazine is a fungicide and inhibit the growth of Rhizobium sp. and E. coli. Anilazine inhibits glucose oxidation and succinate oxidation and also inhibits in vitro succinic dehydrogenase activity[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Anilazine | 98.50% | Anilazine is a fungicide and inhibit the growth of Rhizobium sp. and E. coli. Anilazine inhibits glucose oxidation and succinate oxidation and also inhibits in vitro succinic dehydrogenase activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Anilazine (Standard) | ≥98% | Anilazine (Standard) is the analytical standard of Anilazine. This product is intended for research and analytical applications. Anilazine is a fungicide and inhibit the growth of Rhizobium sp. and E. coli. Anilazine inhibits glucose oxidation and succinate oxidation and also inhibits in vitro succinic dehydrogenase activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Anilazine-d4 | Anilazine-d4 is the deuterium labeled Anilazine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dichlorophenyl-ABA | 99.79% | Dichlorophenyl-ABA is an inhibitor of transthyretin (TTR) amyloid fibril formation, inhibiting aggregate formation in more than 80% in TTR L55P-expressing cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
KEA1-97 | 98.05% | KEA1-97 is a selective Thioredoxin-caspase 3 interaction disruptor (IC50=10 μM). KEA1-97 disrupts the interaction of thioredoxin with caspase 3, activates caspases, and induces apoptosis without affecting thioredoxin activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Diclofenac (Standard) | 99.91% | Diclofenac (Standard) is the analytical standard of Diclofenac. This product is intended for research and analytical applications. Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Diclofenac-13C6 | 99.90% | Diclofenac-13C6 is the 13C6 labeled Diclofenac. Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Irsogladine | 99.88% | Irsogladine (Dicloguamine) is an orally active gastric mucosal protective agent. Irsogladine inhibits breast cancer recurrence and lung metastasis in nude mice. Irsogladine inhibits the transcriptional activities of NF-κB and AP-1, suppresses the activities of PDE and PDE4 to elevate intracellular cAMP levels, and activates TRPV1 and KATP channels. Irsogladine enhances iNOS expression, NO production, and the activation of cAMP-responsive elements. Irsogladine inhibits the development and progression of intestinal polyps in Apc-mutant mice. Irsogladine alleviates oxidative stress, increases gastric mucosal blood flow, and stimulates the production of endogenous prostaglandins. Irsogladine promotes insulin secretion in MIN6 cells. Irsogladine inhibits tumor angiogenesis, cancer cell proliferation, and the production of proinflammatory cytokines. Irsogladine exerts protective effects on astrocytes in ethanol/hydrochloric acid-induced gastric ulcers in mice. Irsogladine prevents colitis in IL-10 gene-deficient mice by reducing the production of IL-12 and IL-23. Irsogladine upregulates gap junction intercellular communication in pancreatic cancer cells via the PKA pathway. Irsogladine is applicable to research related to breast cancer, intestinal polyposis, gastric ulcer, spontaneous colitis, glioma, liver cancer, and pancreatic cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Chlorazanil hydrochloride | Chlorazanil hydrochloride is an orally effective diuretic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Diclofenac impurity 8 | Diclofenac impurity 8 (Diclofenac impurity B) is an impurity of Diclofenac. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Diclofenac impurity 6 | Diclofenac impurity 6 is an impurity of Diclofenac. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Diclofenac impurity 9 | Diclofenac impurity 9 is an impurity of Diclofenac. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
